Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility

PURPOSE: This study aimed to ensure the convenience of administration and reproducibility of efficacy, regardless of the meal, by improving the solubility of rivaroxaban (RIV). METHODS: RIV is a non-vitamin K antagonist oral anticoagulants that exhibits a coagulation effect by directly inhibiting co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ji-Hyun, Lee, Ji-Eun, Jeong, So-Jeong, Park, Chun-Woong, Kim, Dong-Wook, Weon, Kwon-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767707/
https://www.ncbi.nlm.nih.gov/pubmed/36561308
http://dx.doi.org/10.2147/DDDT.S389884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767707/
https://www.ncbi.nlm.nih.gov/pubmed/36561308
http://dx.doi.org/10.2147/DDDT.S389884

Ejemplares similares